A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe

PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006727. doi: 10.1371/journal.pntd.0006727. eCollection 2018 Oct.

Abstract

A young, healthy traveler returning to the United States presented with fever, night sweats, splenomegaly, and pancytopenia. Bone marrow biopsy revealed leishmaniasis (Leishmania infantum), likely acquired in southern France. Although many cases of endemic visceral leishmaniasis (VL) have been reported in Europe, this is a rare case of imported VL in a healthy traveler returning from Europe to the US. Despite successful initial treatment with liposomal amphotericin B (LamB), relapse occurred. Treatments for VL in immunocompetent individuals are highly effective, but relapse can occur. There is more extensive experience in endemic areas with treating relapse that may be lacking in North America. This case alerts physicians in the US that immunocompetent adults can acquire VL during brief visits to endemic areas in Europe. It is important that travelers be counseled on preventive measures. Patients should be monitored after treatment for relapse.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / therapeutic use
  • Biopsy
  • Bone Marrow / parasitology
  • Communicable Diseases, Imported / diagnosis*
  • Communicable Diseases, Imported / drug therapy
  • Communicable Diseases, Imported / parasitology
  • Communicable Diseases, Imported / pathology*
  • France
  • Humans
  • Leishmania infantum / isolation & purification*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / parasitology
  • Leishmaniasis, Visceral / pathology*
  • Male
  • Recurrence
  • Travel*
  • United States
  • Young Adult

Substances

  • Antiprotozoal Agents
  • liposomal amphotericin B
  • Amphotericin B

Grants and funding

The authors received no specific funding for this work.